Objective: Endoscopic ultrasound-guided-fine needle aspiration (EUS-FNA) is an established first-line procedure in the management of solid and cystic pancreatic masses. Lymphoma is an uncommon diagnosis in EUS-FNA of the pancreas, and it is more common for such a diagnosis to be because of secondary involvement of the pancreas by a lymphoproliferative disorder than for this to represent isolated primary pancreatic lymphoma (PPL). We present the clinical, EUS and cytological features of these lesions.
| INTRODUCTION
Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is an established first-line procedure in the management of solid and cystic pancreatic masses. Rapid onsite evaluation (ROSE) has increased the sensitivity of this procedure to over 90%. [1] [2] [3] [4] Pancreatic lymphoma can be difficult to differentiate, on conventional radiology, from pancreatic adenocarcinoma. Definitive distinction between these two entities is obviously important as the treatment of each is very different. 5 It is more common for lymphoma of the pancreas to represent secondary involvement of the organ by a lymphoproliferative disorder than for this to be true primary pancreatic lymphoma. Primary lymphoma of the pancreas is extremely rare, with an incidence of approximately 0.5% of all pancreatic tumours. Stringent criteria exist for the diagnosis of primary pancreatic lymphoma, including a In the present study, our institutional experience of pancreatic lymphoma diagnosed on EUS-FNA is shared, including clinical, EUS and cytological features of these lesions.
| MATERIALS AND METHODS
After obtaining approval from our Institutional Review Board (IRB), nine cases of lymphoma diagnosed on EUS-FNA at a tertiary care
cancer centre over a period of 8 years from 2008 to 2016 were retrieved from our endoscopy and pathology archives.
Rapid onsite evaluation (ROSE) was carried out by a trained cytopathologist in all these cases. All cases were found to be adequate on ROSE. There was an average of three passes on EUS. Cell blocks were available in seven cases, and immunophenotyping was performed on cell blocks using the immunoperoxidase method. Flow cytometry was performed in two cases.
In all cases, the endoscopic findings, histological sub-type, immunohistochemical findings and flow cytometry results were analysed and recorded.
Primary pancreatic lymphoma (PPL) was diagnosed only when the criteria referred to above were met. All other cases were diagnosed as lymphoma secondarily involving the pancreas.
| RESULTS
The mean age of the patients seen was 40 years, ranging from 10 to 70. Five patients were males; four were females. The mean size of the pancreatic mass was 4 cm on EUS (Figure 1 ).
The most frequent site of involvement was the head of the pancreas (n=5, 55.6%) followed by one case each in the body and the tail. In one case, the entire pancreas appeared to be involved in a diffuse manner, whereas in the last, disease appeared confined to peri-pancreatic lymph nodes.
Four out of nine cases were diagnosed as PPL (44.4%). Five cases were diagnosed as lymphoma secondarily involving the pancreas (55.6%). Patients diagnosed as having secondary involvement of the pancreas by lymphoma also showed, variably, nodal disease, gastric, nasopharyngeal and paraspinal soft tissue involvement (Table 1 ).
The most frequent diagnosis was diffuse large B cell lymphoma (n=6, 66.7%), followed by Hodgkin's lymphoma (n=2, 22.2%) and peripheral T cell lymphoma (n=1, 11.1%).
All four cases of PPL were diagnosed as -DLBCL, based on cytomorphological features, immunohistochemical and flow cytometric results ( Figure 2 ). Of the five cases of secondary pancreatic lymphoma, two were diagnosed with -DLBCL, two as classic Hodgkin's lymphoma and one as peripheral T-cell lymphoma, NOS ( Table 2 ).
The most frequent diagnosis was DLBCL (n=6, 66.7%), followed by Hodgkin's lymphoma (n=2, 22.2%) and then peripheral T cell lymphoma (n=1, 11.1%).
In five cases the cytological impression of lymphoproliferative disorder was further confirmed by subsequent histological biopsy and immunophenotyping. The most common lymphoma subtype in the pancreas is NHL.
The differential diagnosis of pancreatic lymphoma includes pancreatic adenocarcinoma, pancreatic neuroendocrine tumours, chronic pancreatitis and other pancreatic lesions. 16 Pancreatic lymphoma can primarily emanate from pancreatic parenchyma or secondarily involve the pancreas from peri-pancreatic or abdominal nodal masses. 17 In a study by Volmar et al., 18 1050 FNA cases were evaluated and out of these only 14 cases were diagnosed as pancreatic lymphoma. In another review, 207 cases were diagnosed as malignant pancreatic tumours and only 3 cases were further classified as pancreatic lymphoma. 19 These studies show that pancreatic lymphoma is an extremely uncommon entity.
The present findings also revealed that pancreatic lymphoma occurs more commonly in males (55.6%). This is in accordance with other studies that have shown a similar male preponderance. 20, 21 The mean age of patients in our series was 40 years, which is again in accordance with the available literature. Pancreatic lymphoma often occurs at a younger age than pancreatic adenocarcinoma. 20, 21 The mean size of the lesion in our review was 4 cm. Johnson et al. 16 reported a mean size of pancreatic lymphomas between 4-5 cm. In the present study, most pancreatic lymphomas involved the head of the pancreas (55.6%). Lin et al. 5 showed similar results, with three out of six cases involving the head, two the body and tail and one case involving the entire pancreas.
In our study, after histological correlation, the most common diagnosis was large diffuse B-cell lymphoma n=6, followed by Hodgkin's lymphoma n=2 and peripheral T-cell lymphoma n=1.
This study showed four PPL and five lymphomas secondarily involving the pancreas. In the cases where pancreatic involvement was felt to be secondary, the primary site of involvement was lymph nodes and other organs such as the stomach, paraspinal soft tissue and nasopharynx.
Among lymphomas involving the pancreas, most are B cell lymphomas, likely DLBCL. 1, 7, 8 Only a few cases of primary T-cell pancreatic lymphoma have been reported. 20, 22 In the literature, lymphomas secondarily involving the pancreas are more frequent than PPL. Based on the present findings, we believe that EUS-FNA is a valuable diagnostic tool for procuring adequate on-site cytological material, and this material along with cytomorphological evaluation, cell block, immunohistochemistry, flow cytometry and molecular studies, e.g., FISH can better help in diagnosing and categorizing pancreatic lymphomas. 
CONCLUSI ON
EUS-FNA in experienced hands, in conjunction with ROSE, immunohistochemistry and flow cytometry, is a valuable diagnostic modality for diagnosing and subtyping both primary pancreatic and secondary pancreatic lymphoma.
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